SCHEMBL32690670

SCHEMBL32690670

Nc1ccc2[nH]c(-c3ccccc3F)c(O)c(=O)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.48
▸ CDK5 Q00535 3/20 0.46
▸ CDK5R1 Q15078 3/20 0.46
▸ CCNB2 O95067 2/20 0.46
▸ CDK1 P06493 2/20 0.46
▸ CCNB1 P14635 2/20 0.46
▸ GSK3B P49841 2/20 0.46
▸ CCNB3 Q8WWL7 2/20 0.46
▸ NMUR2 Q9GZQ4 1/20 0.44
▸ STK17B O94768 1/20 0.44
▸ FLT3 P36888 1/20 0.44
▸ TUBB4A P04350 2/20 0.42
▸ TUBB P07437 2/20 0.42
▸ TUBA3C P0DPH7 2/20 0.42
▸ TUBA1B P68363 2/20 0.42
▸ TUBA4A P68366 2/20 0.42
▸ TUBB4B P68371 2/20 0.42
▸ TUBB3 Q13509 2/20 0.42
▸ TUBB2A Q13885 2/20 0.42
▸ TUBB8 Q3ZCM7 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32690798 0.84 PARP1 (0.48) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL32690794 0.84 NMUR2 (0.50) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL32690706 0.84 AR (0.51) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL32690699 0.80 CTSV (0.59) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL23791621 0.77 TUBB4A (0.54) NMUR2TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL32690820 0.75 HDAC1 (0.44) —
SCHEMBL32690795 0.74 CCNB2 (0.45) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL32690833 0.73 AR (0.51) PARP1CDK5CDK5R1CCNB2CDK1
SCHEMBL17786339 0.72 NMUR2 (0.70) NMUR2KDM4EALDH1A1MEN1KMT2A
SCHEMBL354414 0.72 GAA (0.67) PARP1CDK5CDK5R1CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US claimed
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition TAIWANJ PHARMACEUTICALS CO LTD (TW) 2026-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085046-A1 Dual Function Compounds For NADPH Oxidase Inhibition And Histone Deacetylase Inhibition NOX1, NOX4, CYBB PARP1 113/4885CDK5 1932/4885CDK5R1 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback